Colorado Aims to Let Pharmacists Write Own Prescriptions for HIV Prevention Drugs
March 3rd 2020The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."
Read More
FDA Grants Fast Track Designation to Treatment for Systemic Sclerosis
March 3rd 2020The designation was granted to Emerald Health Pharmaceuticals’ EHP-101, an oral formulation of a novel aminoquinone synthetic derivative of cannabidiol endowed with dual peroxisome proliferator-activated receptor gamma and cannabinoid receptor type 2 agonist activity.
Read More
U=U Continues to Unite HIV Community, Dismantle Stigma Around the Epidemic
March 3rd 2020The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.
Read More
4 Pharmacy Groups Document Support in Supreme Court Case Seeking to Limit PBMs
March 3rd 2020The National Community Pharmacists Association, the Arkansas Pharmacists Association, the American Pharmacists Association, and the National Alliance of State Pharmacy Associations took the joint action of filing an amicus brief in the Supreme Court case [Arkansas Attorney General Leslie] Rutledge v. the Pharmaceutical Care Management Association, scheduled to be heard in Washington, DC on April 27, 2020.
Read More
Report: Increases in Drug Rebates Associated with Rise in list Prices
February 27th 2020According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.
Read More